Skip to content

Two Ayurvedic lep Savarnakar Lepa and Moolakbeej Avalgujadi Lepa on whitishskin condition where white patches appear on the skin

A Comparative Pharmaceutico clinical study on SAVARNAKAR LEPA AND MOOLAKBEEJ AVALGUJADI LEPA and their effect on Shvitra w.s.r to VITILIGO - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092422
Enrollment
60
Registered
2025-08-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

Dr BIJAY KUMAR JAISWAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Selected sign and symptoms based on both ayurvedic and modern context Patients having lakshana of Shvitra as per Ayurvedic text

Exclusion criteria

Exclusion criteria: (a) Age group below 20 and above 70 years. (b) Having complications like renal disease etc. (c) Patients having any other systemic illness. (d) Patient of Shvitra having secondary infection. (f) Patients associated with Diabetes. (g) Patients having AIDS, HeptB, Leukaemia. (h) Pregnant women and lactating mothher.

Design outcomes

Primary

MeasureTime frame
TO EVALUATE THE EFFECT OF SAVARNAKAR LEPA - MOOLAKBEEJ AVALGUJADI LEPATimepoint: PATIENTS WILL BE EVALUATED AFTER EVERY 15 DAYS OUT OF 90 DAYS TRAIL

Secondary

MeasureTime frame
To study the preparation of Safe, effective, and quality drug and standardization.Timepoint: 90 DAYS

Countries

India

Contacts

Public ContactDr Prof PRABHAT KUMAR DWIVEDI

GOVERNMENT AYURVEDIC COLLEGE AND HOSPITAL PATNA BIHAR

drprabhatkd@gmail.com9431172175

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026